Task Group 174 Report: Utilization of [<sup>18</sup> F]Fluorodeoxyglucose Positron Emission Tomography ([<sup>18</sup> F]FDG-PET) in Radiation Therapy.

dc.contributor.author

Das, Shiva K

dc.contributor.author

McGurk, Ross

dc.contributor.author

Miften, Moyed

dc.contributor.author

Mutic, Sasa

dc.contributor.author

Bowsher, James

dc.contributor.author

Bayouth, John

dc.contributor.author

Erdi, Yusuf

dc.contributor.author

Mawlawi, Osama

dc.contributor.author

Boellaard, Ronald

dc.contributor.author

Bowen, Stephen R

dc.contributor.author

Xing, Lei

dc.contributor.author

Bradley, Jeffrey

dc.contributor.author

Schoder, Heiko

dc.contributor.author

Yin, Fang-Fang

dc.contributor.author

Sullivan, Daniel C

dc.contributor.author

Kinahan, Paul

dc.date.accessioned

2021-04-01T21:57:24Z

dc.date.available

2021-04-01T21:57:24Z

dc.date.issued

2019-10

dc.date.updated

2021-04-01T21:57:23Z

dc.description.abstract

The use of positron emission tomography (PET) in radiation therapy (RT) is rapidly increasing in the areas of staging, segmentation, treatment planning, and response assessment. The most common radiotracer is 18 F-fluorodeoxyglucose ([18 F]FDG), a glucose analog with demonstrated efficacy in cancer diagnosis and staging. However, diagnosis and RT planning are different endeavors with unique requirements, and very little literature is available for guiding physicists and clinicians in the utilization of [18 F]FDG-PET in RT. The two goals of this report are to educate and provide recommendations. The report provides background and education on current PET imaging systems, PET tracers, intensity quantification, and current utilization in RT (staging, segmentation, image registration, treatment planning, and therapy response assessment). Recommendations are provided on acceptance testing, annual and monthly quality assurance, scanning protocols to ensure consistency between interpatient scans and intrapatient longitudinal scans, reporting of patient and scan parameters in literature, requirements for incorporation of [18 F]FDG-PET in treatment planning systems, and image registration. The recommendations provided here are minimum requirements and are not meant to cover all aspects of the use of [18 F]FDG-PET for RT.

dc.identifier.issn

0094-2405

dc.identifier.issn

2473-4209

dc.identifier.uri

https://hdl.handle.net/10161/22517

dc.language

eng

dc.publisher

Wiley

dc.relation.ispartof

Medical physics

dc.relation.isversionof

10.1002/mp.13676

dc.subject

Humans

dc.subject

Radioactive Tracers

dc.subject

Fluorodeoxyglucose F18

dc.subject

Positron-Emission Tomography

dc.subject

Neoplasm Staging

dc.subject

Treatment Outcome

dc.subject

Radiotherapy

dc.subject

Radiotherapy Planning, Computer-Assisted

dc.subject

Biological Transport

dc.subject

Quality Control

dc.subject

Image Processing, Computer-Assisted

dc.subject

Respiratory-Gated Imaging Techniques

dc.subject

Research Report

dc.title

Task Group 174 Report: Utilization of [18 F]Fluorodeoxyglucose Positron Emission Tomography ([18 F]FDG-PET) in Radiation Therapy.

dc.type

Journal article

duke.contributor.orcid

Yin, Fang-Fang|0000-0002-2025-4740|0000-0003-1064-2149

duke.contributor.orcid

Sullivan, Daniel C|0000-0002-7556-5650

pubs.begin-page

e706

pubs.end-page

e725

pubs.issue

10

pubs.organisational-group

School of Medicine

pubs.organisational-group

Duke Clinical Research Institute

pubs.organisational-group

Radiology

pubs.organisational-group

Duke

pubs.organisational-group

Institutes and Centers

pubs.organisational-group

Clinical Science Departments

pubs.organisational-group

Duke Kunshan University Faculty

pubs.organisational-group

Duke Cancer Institute

pubs.organisational-group

Radiation Oncology

pubs.organisational-group

Duke Kunshan University

pubs.publication-status

Published

pubs.volume

46

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
AAPM FDG TG Report Das Med Physics 2019.pdf
Size:
894.84 KB
Format:
Adobe Portable Document Format